{"slug":"tesamorelin-ibd","verification":{"valid":true,"entries":2,"head":"5ef59e84c673591e84f3b997a4453ca57fe6a5fca4a24ca13aed6719fee05f59"},"energy":{"passes":2,"tokens_in":22871,"tokens_out":2681,"tokens_total":25552,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"5ef59e84c673591e84f3b997a4453ca57fe6a5fca4a24ca13aed6719fee05f59"},"provenance":[{"ts":"2026-06-29T23:20:09.161Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: Tesamorelin for Ibd\nSlug: tesamorelin-ibd\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"IBD (Crohn's / colitis)\",\"condition_key\":\"ibd-crohns-colitis\",\"primary_peptide\":\"tesamorelin\",\"peptides_in_scope\":[{\"id\":\"tesamorelin\",\"name\":\"Tesamorelin\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have IBD (Crohn's / colitis)\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"tesamorelin\",\"name\":\"Tesamorelin\",\"section_title\":\"Why Tesamorelin might help you\",\"layer\":\"GH axis / visceral fat\",\"steps\":[\"You are reading about **IBD (Crohn's / colitis)** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **IBD (Crohn's / colitis)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\",\"section_headings\":[\"What's breaking down if you have IBD (Crohn'","response":"{\n  \"slug\": \"tesamorelin-ibd\",\n  \"title\": \"Tesamorelin for IBD: Growth Hormone Axis Evidence in Crohn's and Colitis\",\n  \"body\": \"## What's breaking down if you have IBD (Crohn's / colitis)\\n\\nIBD involves ongoing damage to the intestinal lining where inflammation outpaces repair. Layers include barrier breakdown that lets contents leak, chronic cytokine-driven inflammation, impaired mucosal healing, and possible systemic effects like altered metabolism. GH and IGF-1 pathways support epithelial and mesenchymal cell growth plus immune cell balance in gut tissue. When these signals weaken or inflammation blocks them, repair lags and symptoms persist. Tesamorelin enters the discussion here because it raises endogenous GH via GHRH stimulation, which preclinical work links to trophic effects on gut cells.\\n\\n## Why Tesamorelin might help you\\n\\n1. You are reading about **IBD (Crohn's / colitis)** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, Tesamorelin is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nIf your IBD includes metabolic or visceral fat contributions that add systemic load, the GH axis route may intersect with tissue repair signals studied in growth factor research. Tesamorelin raises GH and IGF-1 levels in human trials focused on fat reduction. Those same signals show trophic effects on intestinal cells in separate GH studies. The logic chain stays at the repair layer: elevated GH could support epithelial survival and mucosal recovery if that pathway is relevant to your breakdown profile.\\n\\n## How these fit together\\n\\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **Tesamorelin** → GH axis / visceral fat\\n\\nThis keeps the discussion on one degeneration layer per compound without overlap.\\n\\n## What the evidence actually shows\\n\\nHuman data on Tesamorelin its","tokens_in":22871,"tokens_out":2681,"cost":0,"prev":"genesis","hash":"a997429b28f93ef7d438c75e71e38a2c0c8779b9a3db68f73a5e17f05bfecdef"},{"ts":"2026-07-17T02:42:23.490Z","model":"owner","action":"voxel_divide","prompt":"","input":"tesamorelin-ibd","response":"23 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"a997429b28f93ef7d438c75e71e38a2c0c8779b9a3db68f73a5e17f05bfecdef","hash":"5ef59e84c673591e84f3b997a4453ca57fe6a5fca4a24ca13aed6719fee05f59"}]}